S&P 500 Healthcare Sector SEC Filings — January 27, 2026

28-01-2026

Canadian Pacific Kansas City Ltd filed an 8-K on January 28, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are mentioned. This constitutes a multi-item filing for standard financial results announcement with no detailed performance data provided.

• ·AccNo: 0000016875-26-000004
• ·File Size: 1 MB
• ·Sector: not specified

28-01-2026

Orrstown Financial Services Inc filed a multi-item 8-K on January 28, 2026 (AccNo: 0001628280-26-003716, Size: 5 MB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed. This represents a standard earnings-related voluntary disclosure with no quantified financial impacts provided.

28-01-2026

Zeo ScientifiX, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's identity, position, reason for change, timing, or compensatory arrangements are disclosed.

28-01-2026

Elevance Health, Inc. filed a Form 8-K on 2026-01-28 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure.

28-01-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on January 28, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary.

28-01-2026

News Corp filed an 8-K on January 28, 2026 (AccNo: 0001564708-26-000018), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or strategic impacts are mentioned, resulting in no identifiable positive or negative developments.

28-01-2026

Sound Financial Bancorp, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001541119-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, period-over-period changes, or other quantitative metrics are disclosed in the provided information. No positive or negative performance indicators, guidance, or scheduled events are mentioned.

28-01-2026

Danaher Corp /DE/ filed an 8-K on January 28, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics were disclosed in the provided filing details. This is an informational earnings-related disclosure without quantitative data provided.

28-01-2026

MSCI Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001408198-26-000005), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no quantified metrics available.

28-01-2026

Stifel Financial Corp filed a Form 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No period-over-period comparisons, transaction values, or operational details are provided in the filing metadata.

28-01-2026

CalciMedica, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-025649), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing summary. No quantitative data, positive or negative metrics, or material impacts are explicitly stated.

28-01-2026

CENTRAL PACIFIC FINANCIAL CORP filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or guidance details are disclosed in the provided information. Critical financial metrics and performance data are NOT_DISCLOSED, preventing assessment of positive, negative, or flat trends.

28-01-2026

Civista Bancshares, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item informational filing with no quantitative metrics or directional impacts mentioned.

28-01-2026

Pacira BioSciences, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including officer names, positions affected, appointment or resignation status, reasons, and any financial metrics are NOT_DISCLOSED.

28-01-2026

Ellington Financial Inc. filed an 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement's nature, parties, dollar value, financial impacts, or performance metrics (positive, negative, or flat) are disclosed. This is an informational filing without quantified revenue, earnings, balance sheet effects, or guidance changes.

• ·Filing Accession Number: 0001628280-26-003722
• ·Filing size: 542 KB

28-01-2026

HBT Financial, Inc. filed a Form 8-K on January 28, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, informational disclosure with no quantitative data or scheduled events mentioned.

28-01-2026

Burke & Herbert Financial Services Corp. filed an 8-K on January 28, 2026 (AccNo: 0001964333-26-000008), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, or any quantitative financial metrics are disclosed.

• ·Filing size: 167 KB

28-01-2026

FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed an 8-K on 2026-01-28 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data, scheduled events, or forward-looking statements are mentioned.

28-01-2026

Capitol Federal Financial, Inc. filed a Form 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for quarterly earnings releases. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.

28-01-2026

PROVIDENT FINANCIAL SERVICES INC filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003770, size: 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This is a multi-item voluntary disclosure with no directional financial impacts mentioned.

28-01-2026

LOUISIANA-PACIFIC CORP filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details such as the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, or any quantitative financial metrics are provided. Filing size is 653 KB with no performance data, positive or negative metrics, or period-over-period comparisons mentioned.

28-01-2026

Lexaria Bioscience Corp. filed an 8-K on January 28, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting were disclosed. No specific matters voted on, vote outcomes, numerical results, or other metrics are mentioned in the provided filing information. This appears to be a single-item, mandatory disclosure with no financial or operational details provided.

28-01-2026

KEYCORP /NEW/ filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing description. No quantitative metrics, positive or negative developments, or directional impacts are mentioned.

28-01-2026

BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on January 28, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. Specific details of the other events or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or comparisons provided.

28-01-2026

Beacon Financial Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, or quantitative performance data were disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no details on positive or negative trends.

28-01-2026

Waterstone Financial, Inc. filed an 8-K on 2026-01-28 under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 providing Financial Statements and Exhibits. No quantitative financial metrics, period-over-period changes, revenue, earnings, balance sheet effects, or guidance are disclosed in the provided filing details. This is a multi-item, standard voluntary earnings disclosure with AccNo 0001437749-26-002305 and file size 772 KB.

• ·AccNo: 0001437749-26-002305
• ·File size: 772 KB
• ·Sector: not specified
• ·Critical missing information: All financial metrics, period-over-period comparisons, guidance, scheduled events, named executives or subsidiaries, and detailed results content from exhibits

28-01-2026

FIRST FINANCIAL BANCORP /OH/ filed an 8-K on January 28, 2026 (AccNo: 0000708955-26-000009, size: 7 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the filing description. This is a standard earnings-related disclosure with no quantitative metrics provided.

• ·Accession Number: 0000708955-26-000009
• ·File Size: 7 MB
• ·Event Type: Financial Results

28-01-2026

Cibus, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.

28-01-2026

CITIZENS & NORTHERN CORP filed an 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing description. This appears to be a standard earnings-related disclosure without detailed metrics provided.

28-01-2026

GBank Financial Holdings Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-027228), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance metrics were disclosed in the provided filing information. Sector details were not specified.

28-01-2026

Raymond James Financial Inc filed an 8-K on January 28, 2026 (AccNo: 0000720005-26-000030, size 7 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the filing description. No positive or negative metrics, guidance, or balance sheet impacts are detailed.

28-01-2026

CIMG Inc. filed a Form 8-K on January 28, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No specific financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or market transfer destination were provided.

28-01-2026

Commercial Bancgroup, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing providing voluntary disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, period-over-period comparisons, or directional performance data are mentioned.

28-01-2026

Cingulate Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are disclosed.

28-01-2026

CIMPRESS plc filed an 8-K on January 28, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or other quantitative details are mentioned.

• ·AccNo: 0001262976-26-000002
• ·File size: 9 MB
• ·Sector: NOT_DISCLOSED

28-01-2026

RIVERVIEW BANCORP INC filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. No positive or negative metrics, period-over-period changes, or strategic impacts are mentioned.

28-01-2026

Alerus Financial Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators, guidance, or comparisons are detailed.

28-01-2026

Apollo Commercial Real Estate Finance, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

28-01-2026

Lifeward Ltd. filed an 8-K on 2026-01-28 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and submission of matters to a vote of security holders under Item 5.07. Specific details including key position affected, appointment or resignation status, reasons for change, names, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, period-over-period comparisons, or scheduled events are mentioned.

28-01-2026

MVB Financial Corp filed an 8-K on January 28, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material non-public information, with exhibits likely including a press release or presentation. No specific financial metrics, transactions, quantitative data, positive or negative changes, or operational details are disclosed in the provided filing information.

28-01-2026

ArrowMark Financial Corp. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative changes, or performance comparisons are disclosed in the provided filing summary. This is a multi-item informational filing with no specified sector impacts.

• ·AccNo: 0001999371-26-001905
• ·File Size: 3 MB
• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)

28-01-2026

Enveric Biosciences, Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, which may imply dilutive financing but lacks specific details. Item 9.01 includes financial statements and exhibits. No quantitative transaction values, share counts, or financial impacts are disclosed.